Replies to post #173844 on Biotech Values

[dav1234]

Revance Therapeutics soars following IPO
After pricing its 6M-share IPO at $16, Revance Therapeutics (RVNC) opened at $21 and is now at $26.25, up 64%.The developer of novel botox products currently has a market cap of $465M